Univariate Cox proportional hazards models for survival
Variable . | Relative risk . | 95% CI . | P . |
---|---|---|---|
Age, y | 1.05 | 1.04-1.06 | < .001* |
Ln WBC count | 1.37 | 1.23-1.53 | < .001* |
ALC | 1.59 | 1.39-1.83 | < .001* |
HGB | 0.84 | 0.80-0.88 | < .001* |
PLT count | 0.998 | 0.997-1.00 | .01* |
β-2M | 1.29 | 1.25-1.34 | < .001* |
Ln ALB | 0.07 | 0.04-0.13 | < .001* |
Ln Alk Phos | 2.75 | 2.11-3.60 | < .001* |
Ln LDH | 2.50 | 1.96-3.18 | < .001* |
Ln prolymphs | 1.28 | 1.13-1.46 | .001* |
BM lymphs | 1.01 | 1.01-1.02 | < .001* |
BM cellularity | 1.01 | 1.01-1.02 | < .001* |
Ln spleen size | 1.31 | 1.17-1.46 | < .001* |
Ln liver size | 1.64 | 1.34-2.00 | < .001* |
Ln IgG | 1.04 | 0.81-1.33 | .76 |
Ln IgA | 0.85 | 0.75-0.97 | .02* |
Ln IgM | 0.93 | 0.81-1.07 | .32 |
Time from Dx to MDACC | 1.04 | 1.01-1.08 | .02* |
Variable . | Relative risk . | 95% CI . | P . |
---|---|---|---|
Age, y | 1.05 | 1.04-1.06 | < .001* |
Ln WBC count | 1.37 | 1.23-1.53 | < .001* |
ALC | 1.59 | 1.39-1.83 | < .001* |
HGB | 0.84 | 0.80-0.88 | < .001* |
PLT count | 0.998 | 0.997-1.00 | .01* |
β-2M | 1.29 | 1.25-1.34 | < .001* |
Ln ALB | 0.07 | 0.04-0.13 | < .001* |
Ln Alk Phos | 2.75 | 2.11-3.60 | < .001* |
Ln LDH | 2.50 | 1.96-3.18 | < .001* |
Ln prolymphs | 1.28 | 1.13-1.46 | .001* |
BM lymphs | 1.01 | 1.01-1.02 | < .001* |
BM cellularity | 1.01 | 1.01-1.02 | < .001* |
Ln spleen size | 1.31 | 1.17-1.46 | < .001* |
Ln liver size | 1.64 | 1.34-2.00 | < .001* |
Ln IgG | 1.04 | 0.81-1.33 | .76 |
Ln IgA | 0.85 | 0.75-0.97 | .02* |
Ln IgM | 0.93 | 0.81-1.07 | .32 |
Time from Dx to MDACC | 1.04 | 1.01-1.08 | .02* |
CI indicates confidence interval; Ln, natural log; WBC, white blood cell; ALC, absolute lymphocyte count; HGB, hemoglobin; PLT, platelet; β-2M, β-2 microglobulin; ALB, albumin; Alk Phos, alkaline phosphatase; LDH, lactate dehydrogenase; BM lymphs, bone marrow lymphocytes; prolymphs, prolymphocytes; Dx, diagnosis; MDACC, M. D. Anderson Cancer Center.
Statistically significant.